Nanophage
11 employees on LinkedIn · 2 known investors
Nanophage Technologies develops biological nanorod scaffolds for diagnostic assay applications, enabling enhanced detection and sensitivity in clinical and research settings. The company serves diagnostics manufacturers, pharmaceutical discovery organizations, and clinical laboratories.
Founders & leadership
PS
Paul SmithinChief Executive Officer
DS
Dr Stuart BlinckoChief Technology Officer
Investors · 2
Frequently asked questions
- What does Nanophage do?
- Nanophage Technologies develops biological nanorod scaffolds for diagnostic assay applications, enabling enhanced detection and sensitivity in clinical and research settings. The company serves diagnostics manufacturers, pharmaceutical discovery organizations, and clinical laboratories.
- Who are Nanophage's investors?
- Nanophage's investors include Angel HQ, Bridgewest Ventures.
- Where is Nanophage headquartered?
- Nanophage is headquartered in Unknown, NZ.